Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

New Genetic Loci Identified, Epigenome Explored in Juvenile Idiopathic Arthritis

Thomas R. Collins  |  Issue: April 2017  |  April 19, 2017

science photo/shutterstock.com

science photo/shutterstock.com

WASHINGTON, D.C.—Researchers have identified nine new genetic loci linked with juvenile idiopathic arthritis (JIA), along with evidence that at least some of them likely play a functional role, such as cytokine signaling and T cell expression.

The findings were presented in an abstract session at the 2016 ACR/ARHP Annual Meeting, which also included a presentation on findings on the epigenome in JIA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Genetic Loci Linked to JIA

Researchers pooled 2,751 cases and 15,886 controls from cohorts previously studied, with an eye toward a large, homogeneous population.1 Many previous cohorts have included patients with all of the seven different subtypes of JIA. This cohort included only the similar oligo and rheumatoid factor-negative polyarthritis subtypes, said presenter Laura McIntosh, a graduate student and researcher at the Cincinnati Children’s Medical Center.

In their genome-wide association study, researchers found nine associated regions: JAK1, PRR9_LOR, PTH1R, ILDR1_CD86, FLJ41649, AHI1_LINC00271, HBP1, WDFY4 and RNF215. All had P values of at least 1 x 10(-6), suggesting significance, Ms. McIntosh said. None reached the threshold for genome-wide significance of 1 x 10(-8), but two came close: PRR9_LOR at 5.12 x 10(-8) and ILDR1_CD86 at 6.73 x 10(-8).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Some of these loci are already known to have relevance in immunology. JAK1 elicits signals from cytokines, such as interleukin (IL) 2 and IL-21, to induce IL-17 and IL-6 production. And CD86, which is expressed on antigen-presenting cells, causes stimulation of T cell-expressed CD28 and inhibition of T cell-expressed CTLA-4.

Four of the regions—JAK1, PTH1R, AHI1 and WDFY4—have been found to have roles in other autoimmune diseases, including celiac disease, multiple sclerosis and lupus. But five of the loci appear to be unique to JIA, Ms. McIntosh said.

To assess the functional implications of these loci, researchers queried two expression-quantitative trait loci (eQTL) databases to see whether any of them could affect the expression of their own genes or nearby genes. They found this to be the case for five of the loci.

“This lends to an important regulatory impact on these associated genes,” Ms. McIntosh said.

They also analyzed the single nucleotide polymorphisms (SNPs) for histone modifications in seven cells and found that “there’s evidence for a link between associated loci and potential functional consequences that could affect gene expression,” Ms. McIntosh said.

‘When you look at the histone marks, you see quite different epigenomes in patients with juvenile arthritis,’ Dr. Jarvis said. … ‘These [histone] marks were so significant that you could actually crisply sort out active disease from healthy controls both for K4 mono-methylation & K27 acetylation.’

Epigenetic Markers

In another JIA study, researchers found that neutrophils in children with the disease have epigenetic markers that aren’t seen in healthy children, and that the JIA neutrophil epigenome shows a high degree of plasticity, reorganizing over the course of therapy.2

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsResearch Rheum Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)epigeneticepigenomegenetic lociinflammatory syndromeJIAJuvenile idiopathic arthritisResearchrheumatology

Related Articles

    Genome-Wide Association Studies of SLE

    February 12, 2011

    What do these studies tell us about disease mechanisms in lupus?

    Oksana Kuzmina/shutterstock.comx

    Environmental Factors in Pediatric Systemic Autoimmune Diseases

    March 20, 2017

    Systemic autoimmune diseases are thought to result from immune dysregulation in genetically susceptible individuals who were exposed to environmental risk factors. Many studies have identified genetic risk factors for these diseases, but concordance rates among monozygotic twins are 25–40%, suggesting that nonheritable environmental factors play a more prominent role.1,2 Through carefully conducted epidemiologic and other…

    What Adult Rheumatologists Need to Know about Juvenile Arthritis

    May 1, 2013

    How to recognize distinctions between pediatric and adult arthritis

    The Latest on Epigenetics in Immune-Mediated Disease

    March 19, 2019

    CHICAGO—Because the epigenome has been implicated in a variety of rheumatic conditions, a Basic Research Conference was convened on Epigenetics in Immune-Mediated Disease in conjunction with the 2018 ACR/ARHP Annual Meeting. Melanie Ehrlich, PhD, professor of human genetics and genomics at Tulane University School of Medicine, New Orleans, opened the conference. She has a long…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences